Identifying Autoimmune Encephalitis in Rapidly Progressive Dementia

This study examines the prevalence and clinical characteristics of autoimmune encephalitis (AE) as a significant, treatable cause of rapidly progressive dementia (RPD). Research involving 147 patients revealed that AE is the most frequent reversible diagnosis within this category, often presenting with distinctive features like early-onset seizures and specific imaging abnormalities. Key identified subtypes include anti-LGI1 encephalitis and autoimmune GFAP astrocytopathy, the latter of which frequently manifests through psychiatric symptoms or movement disorders. The findings distinguish AE from non-responsive conditions like Creutzfeldt-Jakob disease, noting that while both can share similar biomarkers, AE symptoms typically emerge earlier and respond well to immunotherapy. Ultimately, the authors emphasize that proactive, comprehensive autoantibody testing in both serum and spinal fluid is essential for preventing diagnostic delays and improving patient outcomes.